ArticleMolecular oncology2024

TPX2 overexpression promotes sensitivity to dasatinib in breast cancer by activating YAP transcriptional signaling.

Carlos Marugán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.